Ardena launches bimonthly newsletter
We are excited to launch our bimonthly newsletter, which is specifically designed to help biotech and pharma companies succeed in their drug development endeavors.
The primary objective of our newsletter is to provide guidance on how to address commonly encountered drug.
With the launch of our bimonthly newsletters, we want to address a range of different topics related to the pharmaceutical industry. Topics of our previously send newsletters were:- What is an acceptable impurity level for a drug substance used in GLP toxicology studies?- When to conduct a polymorph screening?
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance